Vancomycin-intermediate (VISA) and Vancomycin-resistant Staphylococcus aureus (VRSA)
General Information:
- Staphylococcus aureus
- About Vancomycin-resistant Staphylococcus aureus: For Everyone
- VISA/VRSA Infections
HEALTHCARE PROVIDERS
Vancomycin-intermediate and Vancomycin-resistant Staphylococcus aureus: reportable to the local health department within 24 HOURS.
Reporting Guidelines:
Outbreaks: reportable to the local health department IMMEDIATELY
- Contact Local Health Departments
- SHEA/APIC Guideline: Infection Prevention and Control in the Long-term Care Facility
- CDC Guidelines for Disinfection and Sterilization
- EPA's Registered Antimicrobial Products Effective Against MRSA and VRE
- Ohio Department of Health: Vancomycin-intermediate and Vancomycin-resistant Staphylococcus aureus - VISA/VRSA
- CDC Reminds Clinical Laboratories and Healthcare Infection Preventionists of their Role in the Search and Containment of VRSA: January 2022 Update
